Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

79 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and Safety of Antidepressants in Patients With Comorbid Depression and Medical Diseases: An Umbrella Systematic Review and Meta-Analysis.
Köhler-Forsberg O, Stiglbauer V, Brasanac J, Chae WR, Wagener F, Zimbalski K, Jefsen OH, Liu S, Seals MR, Gamradt S, Correll CU, Gold SM, Otte C. Köhler-Forsberg O, et al. JAMA Psychiatry. 2023 Dec 1;80(12):1196-1207. doi: 10.1001/jamapsychiatry.2023.2983. JAMA Psychiatry. 2023. PMID: 37672261 Free PMC article.
Statins in the treatment of depression: Hype or hope?
Köhler-Forsberg O, Otte C, Gold SM, Østergaard SD. Köhler-Forsberg O, et al. Pharmacol Ther. 2020 Nov;215:107625. doi: 10.1016/j.pharmthera.2020.107625. Epub 2020 Jul 8. Pharmacol Ther. 2020. PMID: 32652185 Review.
Comorbid depression in medical diseases.
Gold SM, Köhler-Forsberg O, Moss-Morris R, Mehnert A, Miranda JJ, Bullinger M, Steptoe A, Whooley MA, Otte C. Gold SM, et al. Nat Rev Dis Primers. 2020 Aug 20;6(1):69. doi: 10.1038/s41572-020-0200-2. Nat Rev Dis Primers. 2020. PMID: 32820163 Review.
Candidate diagnostic biomarkers for neurodevelopmental disorders in children and adolescents: a systematic review.
Cortese S, Solmi M, Michelini G, Bellato A, Blanner C, Canozzi A, Eudave L, Farhat LC, Højlund M, Köhler-Forsberg O, Leffa DT, Rohde C, de Pablo GS, Vita G, Wesselhoeft R, Martin J, Baumeister S, Bozhilova NS, Carlisi CO, Leno VC, Floris DL, Holz NE, Kraaijenvanger EJ, Sacu S, Vainieri I, Ostuzzi G, Barbui C, Correll CU. Cortese S, et al. World Psychiatry. 2023 Feb;22(1):129-149. doi: 10.1002/wps.21037. World Psychiatry. 2023. PMID: 36640395 Free PMC article.
Effect of the GLP-1 receptor agonist semaglutide on metabolic disturbances in clozapine-treated or olanzapine-treated patients with a schizophrenia spectrum disorder: study protocol of a placebo-controlled, randomised clinical trial (SemaPsychiatry).
Sass MR, Danielsen AA, Köhler-Forsberg O, Storgaard H, Knop FK, Nielsen MØ, Sjödin AM, Mors O, Correll CU, Ekstrøm C, Vinberg M, Nielsen J, Vilsbøll T, Fink-Jensen A. Sass MR, et al. BMJ Open. 2023 Jan 31;13(1):e068652. doi: 10.1136/bmjopen-2022-068652. BMJ Open. 2023. PMID: 36720576 Free PMC article.
An umbrella review of candidate predictors of response, remission, recovery, and relapse across mental disorders.
Solmi M, Cortese S, Vita G, De Prisco M, Radua J, Dragioti E, Köhler-Forsberg O, Madsen NM, Rohde C, Eudave L, Aymerich C, Pedruzo B, Rodriguez V, Rosson S, Sabé M, Hojlund M, Catalan A, de Luca B, Fornaro M, Ostuzzi G, Barbui C, Salazar-de-Pablo G, Fusar-Poli P, Correll CU. Solmi M, et al. Mol Psychiatry. 2023 Sep;28(9):3671-3687. doi: 10.1038/s41380-023-02298-3. Epub 2023 Nov 13. Mol Psychiatry. 2023. PMID: 37957292 Free PMC article.
79 results